Tekmira stock soars after FDA relaxes precautions on experimental Ebola drug
TORONTO - Shares of Tekmira Pharmaceuticals Corp. (TSX:TKM) shot up about 47 per cent Friday following a U.S. regulatory decision that relaxes safety precautions on the Vancouver-based company's experimental drug for treating Ebola.
The rare disease has killed nearly 1,000 people in West Africa since an outbreak began in March.
Tekmira has a $140-million contract from the U.S. government to develop its drug TKM-Ebola but last month a small human trial of the experimental drug was put on hold after safety issues emerged.
The company said Thursday that the U.S. Food and Drug Administration has "verbally confirmed" that the hold has been modified so Tekmira can make the drug available, even though it has yet to be proven safe and effective.
Tekmira stock jumped $7.39 to $23 on Friday, with about 1.7 million shares traded at the Toronto Stock Exchange. The stock closed on Aug. 1 at $15.55.
Read more Business News
- Judge: Banishment OKKamloops
- Weed oil fire burns twoKelowna
- Dinner raises more than $15kKelowna
- Rose vows to end wasteMunicipal Elections 2014
|QHR Technologies Inc||1.11||+0.06|
|Anavex Life Sciences||0.19||-0.0015|
|Copper Mountain Mining||1.94||+0.09|
|Sunrise Resources Ltd||0.06||0.00|
|Mission Ready Services||0.45||+0.06|
This time of year, I always worry about which friends of mine will get caught going off the road in adverse weather conditions. With a little preparation most accidents can be avoided. Having won the...
Photo: Thinkstock.comThe end of record-low rates is nigh, according to one major bank, which has taken a stance and predicted when the Bank of Canada will raise its long-standing overnight rate. &ldq...
The third week in October is “Small Business Week”, a week dedicated to supporting local, small businesses. The week was designed to bring awareness to Canadians about the role small busin...